Share on StockTwits

Aldeyra Therapeutics’ (NASDAQ:ALDX) quiet period is set to end on Wednesday, June 11th. Aldeyra Therapeutics had issued 1,500,000 shares in its initial public offering on May 2nd, StockRatingsNetwork reports. The total size of the offering was $12,000,000 based on an initial share price of $8.00. During the company’s quiet period, insiders and underwriters that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Shares of Aldeyra Therapeutics (NASDAQ:ALDX) remained flat at $6.57 during during mid-day trading trading on Tuesday. Aldeyra Therapeutics has a 52 week low of $6.00 and a 52 week high of $7.78. The stock has a 50-day moving average of $6.63 and a 200-day moving average of $6.63. The company’s market cap is $41.0 million.

Aldeyra Therapeutics, Inc (NASDAQ:ALDX) is a biotechnology company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.